Pathogenesis of viral-induced diabetes

Current Opinion in Infectious Diseases

Volumn 9, Issue 3, 1996, Pages 161-164

  See, Darryl M ^a   Tilles, Jeremiah G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

AUTOIMMUNITY; CELL MEMBRANE; COXSACKIE VIRUS; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; SHORT SURVEY; VIRUS PATHOGENESIS;

EID: 0030016199     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199606000-00006     Document Type: Short Survey

References (30)

1. Kuno S, Itagaki A, Yamazaki I, Katsumoto T, Kurimura T: Pathogenicity of a newly isolated coxsackievirus B4 for mouse pancreas. Acta Virol 1984, 28:433-436.
2. Szopa TM, Wart T, Dronfiled DM, Portwood ND, Taylor KW: Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates. Diabetologia 1990, 33:325-328.
3. See DM, Tilles JG: WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus. Antimicrob Agents Chemother 1993, 37:1593-1598.
4. Bae Y, Hyone-Myong E, Yoon JW: Molecular identification of diabetogenic viral gene. Diabetes 1989, 38:316-320.
5. Ginsberg-Fellner F, Fedun B, Cooper Z: Interrelationships of congential rubella and type 1 insulin-dependent diabetes. In The immunology of diabetes mellitus. Edited by Jaworski MA, Molnar GD, Rajotte RV, Singh B. Amsterdam: Elsevier Science; 1986:279-286.
6. Yoon JW, London WT, Curfman BL, Brown RL, Notkins AL: Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes 1986, 35:712-716.
7. Montgomery LB, Loria RM, Chinchilli VM: Immunodeficiency as primary phenotype of diabetes mutation db. Diabetes 1990, 39:675-682.
8. D'Alessio D: A case-control study of group B coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 1992, 135:1331-1338.
9. Ward KP, Galloway WH, Auchterlonie IA: Congenital cytomegalovirus infection and diabetes. Lancet 1979, 1:497.
10. Jenson AB, Rosenberg HS, Notkins AL: Pancreatic islet-cell damage in children with fatal viral infections. Lancet 1980, 1:354-358.
11. Bartholomaeus WN, O'Donoghue H, Foti D, Lawson CM, Shellam GR: Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology 1988, 64:397-405.
12. Cavallo MG, Baroni MG, Toto A, Gearing AJH, Forsey T, Andreani D, Thorpe R, Pozzilli P: Viral infection induces cytokine release by beta islet cells. Immunology 1992, 75:664-668.
13. Foulis AK, Farquharson MA, Meager A: Immunoreactive interferon alpha in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 1985, 2:1409-1412.
14. von Herrath MG, Allison J, Miller J, Oldstone M: Focal expression of interleukin-2 does not break unresponsiveness to 'self (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of anti-self immune response. J Clin Invest 1995, 95:477-485. This study exemplifies the concept of islet cell destruction via an amnestic response against viral antigens expressed on the cell surface from a previous infection. The cell damage appears to be mediated by cytotoxic T cells.
15. Lee MS, von Herrath M, Reiser H, Oldstone M, Sarvetnick N: Sensitization to self (virus) antigen by in-situ expression of murine interferon gamma. J Clin Invest 1995, 95:486-492.
16. Karounos DG, Wolinski JS, Thomas JW: Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J Immunol 1993, 150:3080-3085.
17. Baekkeskov S, Nielson JH, Marner B, Bilde T, Ludvigsson J, Lernmark A: Autoantibodies in newly diagnosed diabetic children immunoprecipitate specific human pancreatic islet cell proteins. Nature 1982, 298:167-169.
18. Hou J, Said C, Franchi D, Dockstander P, Chatterjee NK: Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients. Diabetes 1994, 43:1260-1266. This excellent study demonstrated that serum from mice infected with the diabetogenic virus CVB4 strain and humans with IDDM reacted with GAD65, coxsackievirus P2-C protein and GAD65 peptides. It provides excellent evidence for the role of molecular mimicry in the pathogenesis of viral-induced diabetes.
19. Atkinson M, Bowman M, Campbell L, Darow B, Kaufman D, Maclaren N: Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994, 94:2125-2129. This study further clarifies the role of molecular mimicry by showing that peripheral blood mononuclear cells from patients with IDDM reacted to both GAD65 and coxsackie P2-C peptides, whereas cells from normal controls did not. The study also showed that peripheral blood mononuclear cell reactivity to non-specific proliferative stimuli were not different between normal controls and patients with IDDM. In addition, the study defined the sequences with significant amino acid homology.
20. Tian J, Lehman P, Kaufman D: T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 1994, 180:1979-1985. This study showed that Y cell crossreactivrty between GAD65 and coxsackie P2-C was accomplished only in the context of a diabetes susceptibility allele. Thus, the study supports the concept that the induction of diabetes requires both genetic susceptibility and crossreactrve T cell responses.
21. See DM, Tilles JG: Pathogenesis of viral-induced diabetes in mice. J Infect Dis 1995, 171:1131-1138. This study of diabetes in mice, induced by CVB4 stain E2, nicely demonstrated the multifactorial process of beta cell destruction. Macrophages, T cells and cytokines were all shown to play a role. In addition, the study showed that persistence of viral RNA in the pancreas was associated with diabetes.
22. Yoon JW, Austin M, Onodera T, Notkins AL: Viral-induced diabetes: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979, 300:1173-1179.
23. Yoon JW, Morishima T, McClintock PR, Austin M, Notkins AL: Viral-induced diabetes mellitus: megovirus infects pancreatic beta cells in strains of mice resistant to the diabetogenic effect of encephalomyocarditis virus. J Virol 1984, 50:684-690.
24. Rittenhouse HG, Oxender DL, Pek S, Ar D: Complement-mediated cytotoxic effects on pancreatic islets with sera from diabetic patients. Diabetes 1980, 29:317-322.
25. Hulinski I, Ziegler B, Cabrera E, Schlosser M, Witt S, Ziegler M: Monoclonal islet surface antibody dependent cellular cytotoxicity mediated by rat splenoytes with the RIN cell line as target. Exp Clin Endocrinol 1989, 93:181-186.
26. Mandrup-Poulson T, Bendtzen K, Nerup J, Dinarello C, Svenson M, Nielson J: Affinity-purified human interleukin-1 is cytotoxic to isolated islets of Langerhans. Diabetologia 1986, 29:63-67.
27. Pukel C, Baquerizo H, Rabinovich A: Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon gamma, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 1988, 37:133-136.
28. Appels B, Burkart V, Kantwerk-Funke G, Funda J, Kolb-Bachofen V, Kolb H: Spontaneous cytotoxicity of macrophages against pancreatic islet cells. J Immunol 1989, 142:3803-3808.
29. Kroncke K, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H: Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun 1991, 175:752-758.
30. Baek HS, Yoon JW: Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 1990, 64:5708-5715.